Abstract
133 - Phase 1 study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK): Safety, pharmacokinetics and efficacy results from the fed population
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have